David Nicholas Email & Phone Number

Achievements • Responsible for sales across 3 territories and product manager with a range of products and as the senior manager was accountable for the strategic running of the business reporting to the GM and CEO.• Member of strategic sales and business development team with the objective of setting new growth targets and objectives. Grew and developed the business from 5 to 25 staff while maintaining responsibility for Queensland sales and operations and overseeing the sales teams in SA and WA providing mentoring and coaching to develop their skills• Created directions, plans and targets for the coming year, examining the prior year’s results and determining the opportunities for growth and development of the business. • Assessed overseas products and member of the executive team who made decisions on the viability of potential products to be commercially successfulAttended numerous international meetings to undertake research on the suitability of the product for the Australian market with a target of 50% market share as benchmarkUndertook discussions and negotiations to secure the agency for those product lines.

• From 2005 – 2010 as Product Manager, with Diasorin Liaison, grew Vitamin D testing from a zero base to 2 million tests pa. and achieved growth from 0 – 80% market share in 2 years placing over 30 instruments.• Successfully released SNIBE Maglumi Immunoassay system to the Australian market at AACB Conference in 2019. This was built upon Immuno’s reputation as a reliable and trusted partner and the strength of relationships developed with key decision makers.The first large Private laboratory group, based in QLD, started using this technology in mid 2020 utilising the system across 2 disciplines Endocrinology and Immunology. This strategic placement aligning the market open for substantial growth across these two disciplines within ANZ.• In 2013 launched Trinity Rapid HIV POCT rapid testing into Australia following a Government initiative to combat the alarming trend in HIV notificationsProduct was submitted for Class 4(High Risk) approval and approved late 2012.By 2015 The trinity Rapid HIV POCT was considered the preferred HIV test for the HIV POC marketEstablished the test into All Govt States Sexual health clinics and peer testing programmes within Australia.IMMUNO provide education programmes on-going training programmes and reported annually to the TGA regarding usage and performance. • 2010 placed the first automated cytogenetics scanning system for Leica Applied Imaging Cytovision into the QLD Cytogenetics Reference laboratory, building on our existing strong relationship with our Vysis Molecular probes. This momentum quickly gained traction and by the following year another 2 systems had been established into QLD with 5 by 2020. This strategy allowed us to hold market share and lock out the competition* Undertook discussions and negotiations to secure the agency for several product lines.

• Achieved significant growth for all IMMUNO product lines within each territory over 29+ years. I have built strong relationships with key opinion leaders and stakeholders in the private and public sector across the country, providing solutions to improve test performances, workflow and turnaround times.• Develop and execute sales strategies for all Immuno product lines• Expand and maintain Sales in QLD, SA, WA• Manage each territory - regular promotional customer visits. • Identify key decision makers and establish firm relationships, identify decision patterns to close new business• Led extensive educational training of the customer’s staff members and ongoing follow on to ensure that staff were fully conversant with the operational functions or the equipment via high standard quality results. • Provide front line technical and troubleshooting support for equipment and reagents* Overachieved Sales targets regularly over a 29 year period* QLD became the Territory of first sale placements for over 20 years